| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/2010 | US20100098683 MUC1 and Galectin-3 |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098674 Use of polypeptides as cocciostat and/or histomonastat |
| 04/22/2010 | US20100098658 Biopolymer Conjugates Comprising an Interleukin-11 Analog |
| 04/22/2010 | US20100098635 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses |
| 04/22/2010 | US20100098630 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides |
| 04/22/2010 | CA2778066A1 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species |
| 04/22/2010 | CA2777486A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | CA2741065A1 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 04/22/2010 | CA2740873A1 Method of making biologically active alpha-beta peptides |
| 04/22/2010 | CA2740801A1 Transducible polypeptides for modifying mitochondrial metabolism |
| 04/22/2010 | CA2740561A1 Bsa-specific antibodies |
| 04/22/2010 | CA2740554A1 Multiligand constructs |
| 04/22/2010 | CA2740326A1 Hydrophobin solution containing antifoam |
| 04/22/2010 | CA2740317A1 Etoposide and doxorubicin conjugates for drug delivery |
| 04/22/2010 | CA2740316A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | CA2740197A1 Modified variant bowman birk protease inhibitors |
| 04/22/2010 | CA2739551A1 Dengue virus neutralizing antibodies and uses thereof |
| 04/22/2010 | CA2739288A1 Immunoenhancer-linked oligomeric hiv vaccines |
| 04/22/2010 | CA2738757A1 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | CA2737595A1 Utilization of fatty acid desaturases from hemiselmis spp. |
| 04/21/2010 | EP2177902A1 Method and system for multi-stage isoelectric focussing |
| 04/21/2010 | EP2177616A1 Soluble zcytor 11 cytokine receptors |
| 04/21/2010 | EP2177613A1 Recombinant vector capable of increasing secretion of Koji mold protease |
| 04/21/2010 | EP2177534A2 Heteroclitic analogs of class i epitopes |
| 04/21/2010 | EP2177533A1 Multiple N-methylated cyclic hexapeptides for treatment of neurogenic inflammation |
| 04/21/2010 | EP2177531A2 Cell permeable peptide |
| 04/21/2010 | EP2177528A1 Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid |
| 04/21/2010 | EP2177231A2 Use of goat serum for veterinary treatment |
| 04/21/2010 | EP2177228A1 DNA vaccination for treatment of autoimmune disease |
| 04/21/2010 | EP2176427A1 Avian influenza chimeric vlps |
| 04/21/2010 | EP2176420A2 Virus derived antimicrobial peptides |
| 04/21/2010 | EP2176413A1 Immunology treatment for biofilms |
| 04/21/2010 | EP2176407A2 Method of patterning a substrate |
| 04/21/2010 | EP2176294A1 Mdl-1 uses |
| 04/21/2010 | EP2176290A1 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
| 04/21/2010 | EP2176289A2 Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |
| 04/21/2010 | EP2176288A2 Tnf superfamily collectin fusion proteins |
| 04/21/2010 | EP2176287A2 Treatment and diagnostic methods for fibrosis related disorders |
| 04/21/2010 | EP2176286A1 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift |
| 04/21/2010 | EP2176285A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/21/2010 | EP2176283A2 Methods and compositions for treating brain diseases |
| 04/21/2010 | EP2175883A2 Chimeric varicella zoster virus-virus like particles |
| 04/21/2010 | EP1819728B1 Il-7 variants with reduced immunogenicity |
| 04/21/2010 | EP1791858B1 Modified vp1-capsid protein of parvovirus b19 |
| 04/21/2010 | EP1730174B1 Peptide carrier for drug delivery |
| 04/21/2010 | EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases |
| 04/21/2010 | EP1354204B2 Hcv antigen/antibody combination assay |
| 04/21/2010 | EP1323730B1 Novel polypeptides and anti-hiv drugs containing the same |
| 04/21/2010 | EP1311930B1 System and method for authenticating a user to a web server |
| 04/21/2010 | EP1141361B1 Compositions and methods for packaging of alphavirus vectors |
| 04/21/2010 | EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof |
| 04/21/2010 | CN1938418B L-glutamic acid-producing microorganism and method for producing L-glutamic acid |
| 04/21/2010 | CN1814761B Pyrroloquinoline quinone synthesis related gene and its coding protein |
| 04/21/2010 | CN1639318B Antimicrobial composition |
| 04/21/2010 | CN101696414A Gene capable of improving radiation resistance of organisms and application thereof |
| 04/21/2010 | CN101696241A Method for inducing and extracting metallothionein from housefly larva |
| 04/21/2010 | CN101696240A Long lasting growth hormone releasing factor derivatives |
| 04/21/2010 | CN101696239A Human oocyte zona pellucida protein multi-epitope chimeric peptide antigen and preparation method thereof |
| 04/21/2010 | CN101696238A Plant total protein extracting solution and application thereof |
| 04/21/2010 | CN101696237A Method for preparing water-solubility corn gluten protein |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/21/2010 | CN101200725B Separating clone of rice wide compatibility gene S5 and uses thereof |
| 04/21/2010 | CN101062950B Polyethylene glycol modified thymus peptide 1 derivative |
| 04/21/2010 | CA2641448A1 Synthetic antigen mimetics matrices immuno-reactive with rheumatoid arthritis auto-antibodies |
| 04/20/2010 | US7702465 Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom |
| 04/20/2010 | US7700853 Inbred corn line XHH13 |
| 04/20/2010 | US7700838 4-hydroxyphenylpyruvate dioxygenases; transformed seeds, cells |
| 04/20/2010 | US7700837 Transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same |
| 04/20/2010 | US7700830 Bacillus thuringiensis insecticidal proteins |
| 04/20/2010 | US7700827 Metal resistant plants and phytoremediation of environmental contamination |
| 04/20/2010 | US7700759 Aptamer constructs |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700754 Polypeptide for unstabilizing protein in cells under aerobic conditions and DNA encoding the same |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700748 VMGLOM gene and its mutations causing disorders with a vascular component |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700736 PRO350 antibodies |
| 04/20/2010 | US7700733 Factor VII or VIIa polypeptide variants |
| 04/20/2010 | US7700732 reconstitution of paste, concentrating, adding stabilizers, pasteurizing |
| 04/20/2010 | US7700731 Prokaryotic collagen-like proteins and uses thereof |
| 04/20/2010 | US7700730 Using viral capsid protein comprising RGD domain (arginine-glycine-aspartic acid) to treat and prevent cell proliferative, nervous system, autoimmune and allergic disorders |
| 04/20/2010 | US7700729 Modified bacteriocins and methods for their use |
| 04/20/2010 | US7700728 Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors |
| 04/20/2010 | US7700727 Compositions and kits for detecting pathogen infection |
| 04/20/2010 | US7700726 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies |
| 04/20/2010 | US7700725 HIV antisense proteins |
| 04/20/2010 | US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 04/20/2010 | US7700721 antiparallel peptide arrangement; self-assembling; bone repair |
| 04/20/2010 | US7700720 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700718 ice nucleation activity; immobilizing fish-derived type III antifreeze proteins on carrier |
| 04/20/2010 | US7700717 cyclic peptides conjugated to photoactive moieties for intraoperative diagnostic imaging, screening and real-time monitoring of photodynamic therapy efficiency |
| 04/20/2010 | US7700715 Kit for use in the diagnosis and treatment of cancer |
| 04/20/2010 | US7700571 Compositions and methods for liver growth and liver protection |
| 04/20/2010 | US7700563 Synthetic heparin-binding factor analogs |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700556 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 04/20/2010 | US7700555 Methods of treating diabetes |